Stock Trim Losses -...
Health Care: Drugs
Cephalon Inc (CEPH: NASDAQ)
$81.49 0.06 | 0.07%
10/13/11 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:16.01
Price Earnings Comparisons:
| CEPH | Sector Avg. | S&P 500 |
|---|---|---|
| 16.01 | 12.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 1.74 | 0.00 | 19.73 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 28.20 | 0.59 | 0.16 |
| Net Income | 24.30 | -3.22 | 0.00 |
| EPS | 19.50 | -2.97 | 0.00 |
Earnings for CEPH:
| EBITDA | 1.11B |
| REVENUE | 2.81B |
Average Earnings Estimates
| Qtr (09/11) | Qtr (12/11) | FY (12/11) | FY (12/12) | |
|---|---|---|---|---|
| Average Estimate | $2.10 | $2.12 | $8.21 | $5.14 |
| Number of Analysts | 8 | 8 | 8 | 9 |
| High Estimate | $2.27 | $2.31 | $8.49 | $6.54 |
| Low Estimate | $1.86 | $1.97 | $7.58 | $2.42 |
| Prior Year | $2.14 | $2.19 | $8.14 | $8.21 |
| Growth Rate (Year over Year) | -1.93% | -3.03% | 0.81% | -37.32% |
Portfolios with CEPH
- Portfolio NameUser Type
- ContributorTop-Rated Biotechnology Stocks
- UserCramer - Rates - A/B
- Userash
- UserPFE
- ProRichard Perry - Perry Capital
- ProEdward Owens
- ContributorPharma Short Squeezes for 2011
- Userinvst2011
- Contributor7 Undervalued Stocks From C...
- Contributor4 Drug Stocks Poised to Sta...
Latest CEPH Headlines from TheStreet
- Tech IPO Offensive, M&A Retreat: Deals to Watch 10.14.11 | 10:10 am
- 8 Stocks Setting New 52-Week Highs 10.12.11 | 02:10 pm
- TE Connectivity to Join S&P 500 10.11.11 | 06:10 pm
- Cephalon Reaches New 52-Week High (CEPH) 10.06.11 | 02:10 pm
- Cephalon Reaches New 52-Week High (CEPH) 09.16.11 | 12:09 pm
- Bridgewater, Alas, Also Lost Money on Stocks 08.15.11 | 07:08 am
- Valeant Talking Takeover of Medicis: Report 08.09.11 | 04:08 am
- Valeant Eyes Meda Takeover: Report 07.27.11 | 04:07 am
- 3 Ways to Make Money From M&A Rebound 07.06.11 | 06:07 am
- Valeant Buys Sanitas to Broaden Generics 05.24.11 | 05:05 am
Press Releases for CEPH
- Teva Completes Acquisition Of Cephalon - Business Wire 10.14.11 | 09:10 am
- Teva And Cephalon Receive European Commission Approval For Acquisition - Business Wire 10.13.11 | 03:10 pm
- Cephalon Receives FDA Approval For Risk Evaluation And Mitigation Strategy For FENTORA And ACTIQ - PR Newswire 07.21.11 | 09:07 am
- Cephalon Shareholders Approve Acquisition By Teva - PR Newswire 07.14.11 | 11:07 am
- Cephalon To Release Second Quarter 2011 Earnings Results After The Market Close On August 2, 2011 - PR Newswire 06.29.11 | 09:06 am
- Faruqi & Faruqi, LLP Announces Investigation Of Cephalon, Inc. - Business Wire 06.24.11 | 08:06 pm
- Cephalon Granted Temporary Restraining Order In AMRIX® Patent Litigation - PR Newswire 05.20.11 | 02:05 pm
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Cephalon, Inc. - Business Wire 05.19.11 | 03:05 pm
- Cephalon Recognizes National Night Shift Worker's Day, Honors America's Shift Workers - PR Newswire 05.11.11 | 09:05 am
- The Law Firm Of Weiss & Lurie Investigates The Acquisition Of Cephalon, Inc. - Business Wire 05.10.11 | 04:05 pm
Partner Headlines for CEPH
- Focus On Billionaire Israel Englander's Top Stock Picks - Seeking Alpha 12.15.11 | 07:12 am
- Zweig DiMenna's Top Stock Picks - Seeking Alpha 12.09.11 | 07:12 am
- Company News for October 21, 2011 - Corporate Summary - Zacks 10.21.11 | 10:10 am
- Stocks Weather Consumer Sentiment Dip on Retail Sales, Google Earnings Strength - NASDAQ 10.14.11 | 04:10 pm
- Mid-Day Update: Stocks Back Off Highs But Firm Despite Consumer Sentiment Drop - NASDAQ 10.14.11 | 04:10 pm
- UPDATE: Teva Completes Acquisition of Cephalon; Cephalon Ceased Trading Today - Benzinga 10.14.11 | 09:10 am
- COOPER TIRE (CTB) - Profit Tracks - Zacks 10.14.11 | 01:10 am
- 3 Undervalued Healthcare Stocks Trading Near Highs - Seeking Alpha 09.23.11 | 07:09 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 09.22.11 | 09:09 am
- Cephalon sues Sandoz over Fentora cancer drug - Reuters 09.16.11 | 09:09 am
